Validation of a population pharmacokinetic model for adjunctive lamotrigine therapy in children

British Journal of Clinical Pharmacology

Volumn 50, Issue 2, 2000, Pages 135-145

  Chen, Chao ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Adjunctive therapy; Children; Lamotrigine; Population pharmacokinetics

Indexed keywords

LAMOTRIGINE; VALPROIC ACID;

ACCURACY; ADOLESCENT; ARTICLE; BAYES THEOREM; CHILD; COVARIANCE; DRUG BLOOD LEVEL; DRUG CLEARANCE; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL MODEL;

ADOLESCENT; ANTICONVULSANTS; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; NONLINEAR DYNAMICS; TRIAZINES;

EID: 0033866254     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00237.x     Document Type: Article

References (33)

1. 1 Leach MJ, Marden CM, Miller AA. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug II. Neurochemical studies on the mechanism of action. Epilepsia 1986; 27: 490-497.
2. 2 Matsuo F, Bergen D, Faught E, et al. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 1993; 43: 2284-2291.
3. 3 Messenheimer J, Ramsay RE, Willmore LJ, et al. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial. Epilepsia 1994; 35: 113-121.
4. 4 Schachter SC, Leppik IE, Matsuo F, et al. Lamotrigine: a six-month, placebo-controlled, safety and tolerance study. J Epilepsy 1995; 8: 201-209.
5. 5 Loiseau P, Yuen AWC, Duche B, Menager T, Arne-Bes MC. A randomized double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures. Epilepsy Res 1990; 7: 136-145.
6. 6 Smith D, Baker G, Davies G, Dewey M, Chadwick DW. Outcomes of add-on treatment with lamotrigine in partial seizures. Epilepsia 1993; 34: 312-322.
7. 7 Schapel GJ, Beran RG, Vajda FJE, et al. Double-blind, placebo controlled, crossover study of lamotrigine in treatment of resistant partial seizures. J Neurol Neurosurg Psychiatry 1993; 56: 448-453.
8. 8 Jawad S, Richens A, Goodwill G, Yuen WC. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia 1989; 30: 356-363.
9. 9 Gilliam F, Vazquez B, Sackellares JC, et al. An active-control trial of lamotrigine monotherapy for partial seizures. Neurology 1998; 51: 1018-1025.
10. 10 Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995; 345: 476-479.
11. 11 Steiner TJ, Yuen AWC. Comparison of lamotrigine (Lamictal) and phenytoin monotherapy in newly diagnosed epilepsy. Epilepsia 1994; 35: 61.
12. 12 Reunanen M, Dam M, Yuen AWC. A randomized open multicenter comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Res 1996; 23: 149-155.
13. 13 Graf WP, Pellock JM, Duchowny M, Womble G, Manasco P. Lamotrigine is effective for add-on treatment of partial seizures in children and adolescents. Epilepsia 1997; 38: 193.
14. 14 Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. N Engl J Med 1997; 337: 1807-1812.
15. 15 Frank LM, Casale EJ, Womble G, Manasco P. Lamictal is effective for the treatment of typical absence seizures in children and adolescents. Ann Neurol 1997; 42: 489.
16. 16 Goa KL, Ross SR, Chrisp P. Lamotrigine: a review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1993; 46: 1-25.
17. 17 Eriksson AS, Hoppu K, Nergardh A, Boreaus L. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy. Epilepsia 1996; 37: 769-773.
18. 18 Vauzelle-Kervroedan F, Rey E, Cieuta C, et al. Influence of concurrent antiepileptic medication on the pharmacokinetics of lamotrigine as add-on therapy in epileptic children. Br J Clin Pharmacol 1996; 41: 325-330.
19. 19 Wallas S. Add-on open trial of lamotrigine in resistant childhood seizures. Brain Dev 1990; 12: 1734.
20. 20 Riva R, Albani F, Contin M, Baruzzi A. Pharmacokinetic interactions between antiepileptic drugs. Clin Pharmacokin 1996; 31: 470-493.
21. 21 Chen C, Grasela TH, Phillips L, Friedler-Kelly JB, Womble G, Risner ME, Yau MK. Population Pharmacokinetics of Add-On Lamotrigine in Pediatric Patients. Ann Neurol 1997; 42: 508.
22. 22 Beal SL, Boeckman AL, Sheiner LB. NONMEM. User' s Guide (Double Precision, Version 4.0, Level 2.0). San Francisco: University of California at San Francisco, 1992.
23. 23 Jawad S, Yuen WC, Peck AW, Hamilton MJ, Oxley JR, Richens A. Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy. Epilepsy Res 1987; 1: 194-201.
24. 24 Yuen WC, Peck AW. Lamotrigine pharmacokinetics: oral and i.v. infusion in man. Br J Clin Pharmacol 1988; 26: 242P.
25. 25 Peck AW. Clinical pharmacology of lamotrigine. Epilepsia 1991; 32: S9-S12.
26. 26 Hussein Z, Posner J. Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data. Br J Clin Pharmacol 1997; 43: 457-465.
27. 27 Sailstad JM, Findlay JWA. Immunofluorometric assay for lamotrigine (Lamictal) in human plasma. Ther Drug Monit 1991; 13: 433-442.
28. 28 Bruno R, Vivier N, Vergniol JC, De Phillips SL, Montay G, Sheiner LB. A population pharmacokinetic model for docetaxel (Taxotere): model building and validation. J Pharmacokin Biopharm 1996; 24: 153-172.
29. 29 Peck CC, Barr WH, Benet LZ, et al. Opportunities for integration of pharmacokinetics, pharmacodynamics and toxicokinetics in rational drug development. Clin Pharmacol Ther 1992; 51: 465-473.
30. 30 Aarons L, Balant LP, Mentre F, et al. Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies. Eur J Clin Pharmacol 1996; 49: 251-254.
31. 31 Roecker EB. Prediction error and its estimation for subset-selected models. Technometrics 1991; 33: 459-468.
32. 32 Efron B. Estimating the error rate of a prediction rule: improvement on cross-validation. J Am Stat Assoc 1983; 78: 316-331.
33. 33 Ette EI. Population model stability and performance. J Clin Pharmacol 1997; 37: 486-495.